RecallDepth
Class II Terminated

Fayosim (levonorgestrel and ethinyl estradiol) tablets USP, (0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg) and ethinyl estradiol tablets USP, (0.01 mg), packaged in 1 Extended-Cycle Wallet of 91 Tablets packed in a pouch(NDC 68180-860-11); one pouch per carton (NDC 68180-860-12), Rx only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.

This recall has been terminated (originally issued April 3, 2019).

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
March 22, 2019
Posted
April 3, 2019
Recall Number
D-1057-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,464 cartons
Firm Location
Baltimore, MD, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impurities) in Ethinyl Estradiol Tablets USP 0.01mg at 12 month long term stability study.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot #: L800016, Exp 12/2019; L800721, Exp 05/2020

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls